ASHXF yields 888.89% · JNJ yields 2.13%● Live data
📍 ASHXF pulled ahead of the other in Year 1
Combined, ASHXF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASHXF + JNJ for your $10,000?
Progressive Planet Solutions Inc., together with its subsidiaries, engages in the acquisition and exploration of mineral properties in Canada. It primarily explores for natural pozzolan deposits. The company holds 100% interest in the Z1 Zeolite mine located 3 kms northeast of Cache Creek, British Columbia; and the Z3 Heffley property situated in Heffley Creek, British Columbia. It also holds interests in Z2 Zeolite property located near Falkland, British Columbia. In addition, the company is involved in converting post-consumer glass into a low carbon cement; manufacture of mineral based products derived from diatomaceous earth, zeolite, and bentonite for use in agricultural, industrial, and consumer applications; and developing solutions for sequestering CO2 and minimizing the carbon footprint. Further, it manufactures industrial minerals, which include industrial absorbents under the CanDry brand; cat litters under the WunderCat brand for retailers; and animal husbandry/agtech products that neutralizes ammonia in chicken barns and enables the birds to breathe easier under the Activated Barn Fresh brand. Progressive Planet Solutions Inc. was incorporated in 2006 and is headquartered in Kamloops, Canada.
Full ASHXF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.